BQL-TB targets the world's leading infectious killer.
BQL-Stress brings lab-grade cortisol quantification to wellness, occupational,
and mental-health settings. Both run on the same architecture.
A high-sensitivity, dual-flow colorimetric rapid diagnostic test targeting urinary TB-LAM, the only validated non-sputum TB biomarker. A single 120 µL urine loading produces a naked-eye-readable result in 15 minutes at a per-test cost below US$1. No laboratory, no dedicated reader, no additional user steps.

A digital healthcare system and point-of-care device for measuring cortisol (stress hormone) levels, built on a polymer Lab-on-a-Chip platform with a published reference in Biomedical Microdevices. Designed for integration with wellness, occupational health, and mental-health screening workflows.

Next-generation In Vitro Diagnostics, built on dual-flow Lab-on-a-Chip technology licensed from the University of Cincinnati.
Products described on this site are in development. They have not been cleared or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. They are not yet available for sale.
© 2026 BQL Healthcare USA Inc. All rights reserved.